Relay Therapeutics CFO Sells 17,717 Shares for $350,000

Catinazzo's pre-arranged sale reduced his direct stake by 11%, but the insider still holds a significant amount of shares.

CryptoAlerta — análise de criptomoedas e mercado em tempo real